BOSTON, April 24, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living ...
~ PEDMARQSI is the First and Only Approved Therapy in the EU and U.K. for the Prevention of Ototoxicity, or Hearing Loss, Induced by Cisplatin Chemotherapy in Patients 1 month to 5% compared to ...
Deutsche Energy Terminal GmbH's (DET) second liquefied natural gas (LNG) terminal in Wilhelmshaven, Germany, has started commercial operations. The Wilhelmshaven 02 terminal, along with the floating ...
Fennec (FENC) Pharmaceuticals announced that Norgine Pharmaceuticals has commercially launched PEDMARQSI in Germany. “Until now, there have been no pharmacological interventions available to cancer ...
SolarEdge Technologies Inc. SEDG recently launched its first commercial storage system, the CSS-OD battery, in Germany. This new battery, paired with SolarEdge’s solar inverter and power optimizer, ...